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A B S T R A C T
Glioblastoma is the most common and most aggressive primary brain malignancy. The multimodality
treatments for this tumor including surgery, radiotherapy, and chemotherapy, are still not completely
satisﬁed. Phenethyl isothiocyanate (PEITC), one member of the isothiocyanate family, has been shown
to induce apoptosis in many human cancer cells. In this study, we investigate the pro-apoptotic effects
caused by PETIC in human brain glioblastoma multiforme GBM 8401 cells.
In our data, PEITC induced the cell morphological changes and decreased the cell viability of GBM8401
cells in a dose- and time-dependent manner. Moreover, the analysis of cell cycle distribution detected
by ﬂow cytometry showed that PEITC induced signiﬁcantly sub-G1 phase (apoptotic population) in GBM
8401 cells. In addition, PEITC promoted the production of reactive oxygen species (ROS) and increase in
[Ca2+]I, but decreased the mitochondrial membrane potential (ΔΨm) in treated cells. PEITC also induced
caspases activities in GBM 8401 cells. Results from Western blot analysis indicated that PEITC pro-
moted Fas, FasL, FADD, TRAIL, caspase-8, -9, -3, increased the pro-apoptotic protein (Bax, Bid and Bak),
and inhibited the anti-apoptotic proteins (Bcl-2 and Bcl-xl) in GBM 8401 cells. Furthermore, PEITC pro-
moted the release of cytochrome c, AIF and Endo G. GADD153, GRP 78, XBP-1 and IRE-1α, Calpain I and
II in GBM 8401 cells. PEITC also promoted the expression of associated protein with endoplasmic re-
ticulum (ER) stress. PEITC induces apoptosis through the extrinsic (death receptor) pathway, dysfunction
of mitochondria, ROS induced ER stress, intrinsic (mitochondrial) pathway in GBM 8401 cells. The pos-
sible molecular mechanisms and signaling pathways of the anti-cancer properties of PEITC for human
brain glioblastoma cells were postulated.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Glioblastoma is the most common and most aggressive primary
brainmalignancy. Evenwithmaximum feasible surgical resectionwith
radiotherapy and adjuvant temozolomide (TMZ), survival rates are
at amedian of 14.6months from diagnosis inmolecularly unselected
patients (Stupp et al., 2005). Radiotherapy and TMZ provide better
survival outcomes than radiotherapy alone to treat glioblastoma (Yang
et al., 2014). Both extent of resection and residual volume are sig-
niﬁcantly associated with survival and recurrence (Chaichana et al.,
2014). Gross total resection is associated with survival improve-
ment, but it is not always possible because the preservation of
neurological functions is necessary. The current multimodality treat-
ments including surgery, radiotherapy, chemotherapy for this tumor
are still not completely satisfying. Phenethyl isothiocyanate (PEITC)
is one of the most extensively studied isothiocyanates (Moon et al.,
2011). Its effective chemopreventive activity for various tumors and
no obvious toxicity in animal models have been reported (Hecht,
1995). PEITC can induce cell cycle arrest and apoptotic cell death
(Antosiewicz et al., 2008; Chen et al., 2002; Hu et al., 2003; Jakubikova
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et al., 2005; Kang and Wang, 2010; Telang et al., 2009; Tseng et al.,
2004). PEITC selectively kills cancer cells, but not normal cells, by gen-
erating reactive oxygen species (ROS) to trigger signal transduction,
leading to cell cycle arrest and/or apoptosis (Wu and Hua, 2007).
Studies have disclosed the cell growth inhibitory effects of PEITC in
human leukemia (Xu and Thornalley, 2000), lung cancer (von
Weymarn et al., 2006), HeLa cervical cancer (Yu et al., 1998), HT-29
colon adenocarcinoma (Hu et al., 2003), pancreatic cancer (Nishikawa
et al., 2004), and human prostate cancer PC-3 cells (Xu et al., 2005).
In human glioma cells, PEITC inhibits the HIF-1α expression through
inhibiting the Phosphoinositide 3-kinase (PI3K) and mitogen acti-
vated protein kinase (MAPK) signaling pathway, and reduces the
hypoxia-induced secretion of vascular endothelial growth factor
(VEGF) (Gupta et al., 2013); PEITC also promoted the actions of tumor
necrosis factor-related apoptosis-induced ligand (TRAIL) through the
upregulation of death receptor-5 (DR5) with ROS-induced-p53 and
the downregulation of cell survival proteins (Lee et al., 2014). But the
overview of mechanisms of PEITC-induced apoptosis of human brain
glioblastoma cells has not been understood well.
In the present study, we investigated the effects of PEITC on
human brain glioblastoma cells including the induction of cell cycle
arrest and apoptosis through the ROS and dysfunction of mitochon-
dria signaling transduction pathways in GBM8401 cells.
2. Materials and methods
2.1. Chemicals and reagents
PEITC, dimethyl sulfoxide (DMSO), propidium iodide (PI), Trypan
blue and 2,7-Dichlorodihydroﬂuorescein diacetate (DCFH-DA) were
obtained from Sigma Chemical Co. (St. Louis, MO, USA). RPMI-
1640, fetal bovine serum (FBS), L-glutamine, penicillin-streptomycin
and trypsin-EDTAwere purchased from Gibco BRL/Invitrogen (Carls-
bad, CA, USA). Primary antibodies (BAX, BCL-2, catalase, Mn-SOD,
cytochrome c, caspase-2, -3, -4, -8 and -9, PARP, GRP78, GADD153
and β-actin) and second antibodies for Western blotting were ob-
tained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). They
were diluted in PBS Tween-20 before use. Fluo-3/AM, DiOC6 and 4′,6-
diamidino-2-phenylindole (DAPI) were obtained from Molecular
Probes (Invitrogen, Eugere, OR, USA).
2.2. Cell culture
Human brain glioblastoma multiforme (GBM 8401) cell line was
purchased from the Food Industry Research and Development In-
stitute (Hsinchu, Taiwan). Cells were plated onto 75 cm2 tissue culture
ﬂasks in RPMI 1640medium supplemented with 10% FBS, 100 U/ml
penicillin and 100 μg/ml streptomycin, 2mM L-glutamine, and grown
at 37 °C under a humidiﬁed 5% CO2 and 95% air at one atmo-
sphere. The medium was changed every 2 days (Wang et al., 2002).
2.3. Cell morphological changes and viability
GBM 8401 cells (2 × 105 cells/well) onto a 24-well plate were
treated with 0, 4, 6, 8, 10, 12, and 14 μM PEITC, or 0, 500 μM TMZ
and were incubated for 0, 24 and 48 h. Cells in each well were ex-
amined andwe took representative photographs at 200×magniﬁcation
by Nikon TE2000-U inverted microscope for morphological change
examinations. After cells from each well were trypanized and col-
lected by centrifugation at 1500 rpm for 5min, washed twice with
PBS, 5 μg/ml PI in PBS was added to the cells to determine the per-
centage of viable cells. Nonviable cellswere stained by PI dye exclusion
(indicative of an intact membrane) and displayed brighter ﬂuores-
cence than the unstained (viable cells). Cells were counted by ﬂow
cytometric analysis with FACSCalibur utilizing Cell Quest software
(Becton-Dickinson, San Jose, CA, USA) (Lu et al., 2010a).
2.4. Determination of cell cycle and apoptosis by ﬂow cytometry
GBM 8401 cells (2 × 105 cells/well) were grown in a 24-well plate
for 24 h then treated with 0, 4, 6 and 8 μM PEITC. Cells were iso-
lated, washed with ice-cold PBS, and then ﬁxed in 70% ethanol
overnight, followed by the re-suspension in PBS containing 40 μg/ml
PI and 0.1 mg/ml RNase and 0.1% Triton X-100 in dark room for
30 min at 25 °C. Cells were washed twice before cell cycle analy-
ses were performed by using a ﬂow cytometer (Beckton-Dickinson)
equipped with an argon ion laser at 488 nm wavelength (Lu et al.,
2010b). Fluorescence intensity of the sub-G1 cell fraction repre-
sented the apoptotic cell population. Each treatment was performed
in triplicate for statistical evaluation.
2.5. Annexin V-FITC/PI double staining
Cell death induced by PEITC was analyzed by ﬂow cytometry.
Cell surface exposure of phosphatidylserine (PS) in apoptotic cells
wasmeasured by Annexin V-FITC Apoptosis Detection Kit (Biovision,
USA). GBM 8401 cells (1 × 105 cells/well) were treated with 8 μM
PEITC for 24 h and then stained with Annexin V-ﬂuorescein
isothiocyanate (FITC) and PI. Cells were washed with PBS after stain-
ing, then were re-suspended in binding buffer and immediately
analyzed using a ﬂuorescence-activated cell sorting (FACS) ﬂow cy-
tometer (Beckman Coulter, USA) (Ho et al., 2013). In ﬂuorescence
channels FL1 (488 nm excitation and 530 nm emission for Annexin
V-FITC binding) and FL2 (488 nm excitation and red emission for
PI), ﬂuorescence from PEITC-treated and untreated cells was detected.
2.6. Detections of reactive oxygen species (ROS), Ca2+ and mito-
chondrial membrane potential (ΔΨm) using ﬂow cytometric assay
GBM 8401 cells (2 × 105 cells/well) onto 24-well plates were
treated with 0, 8 μM PEITC or 0, 500 μM TMZ and incubated for 0,
24 and 48 h. Cells were harvested from each treatment by centrifu-
gation, washed twice with PBS and re-suspended in 500 μL of 2,7-
dichlorodihydroﬂuorescein diacetate (DCFH-DA) (10 μM) for ROS
measurements, in 500 μL of Flou-3/AM (2.5 μg mL) for Ca2+ level
examination and in 500 μL of DiOC6 (200 nmol L) for ΔΨm deter-
mination. All samples from control and PEITC treated groups were
incubated at 37 °C for 30 min in the dark room at 25 °C and ana-
lyzed by ﬂow cytometry (Ho et al., 2013; Lu et al., 2010b).
2.7. Measurements of caspase-3, -8 and -9 activities using ﬂow
cytometric assay
GBM8401cells (5 × 105 cells/well) onto24-well platewere treated
with 0, 8 μM PEITC or 0, 500 μM TMZ and incubated for 0, 24 and
48 h. Cells were harvested, washed twice with PBS then caspase-3,
-8 and -9 substrates (CaspaLux8-L1D2,- CaspaLux 9-M1D2 and
PhiPhiLux-G1D2) were added, respectively. Flow cytometric assay
was applied to measure the activities of caspase-3, -8 and -9 (Ho
et al., 2013).
2.8. Western blotting assay
GBM8401 cells (1 × 106 cells/well) onto 12-well platewere treated
with 6, 8 μM PEITC and incubated for 0, 24 and 48 h to detect the
apoptosis-inducing proteins. Cells were collected and lysed in lysate
buffer composed of 50 μM tris (pH 8.0), 150 μM NaCl, 5 μM
ethylenediaminetetraacetic acid and 0.5% NP-40 with protease in-
hibitor solution (Roche, Mannheim, Germany). The protein
concentration from each treatment was determined by using Bio-
Rad protein assay kit. About 30 μg of protein from each sample
was separated on a 10% sodium dodecyl sulfate-polyacrylamide
electrophoretic gel (SDS-PAGE) and transferred to nitrocellulose
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membranes (GE Healthcare, NJ, USA). The blot was soaked with
blocking buffer of 5% non-fat dry milk in Tris-buffered saline con-
taining Tween-20 (TBS-T) for 1 h at 25 °C. They were incubated
with the speciﬁc primary antibodies. Immunoreactive proteins were
detected with horseradish peroxidase conjugated secondary anti-
bodies and detected by chemiluminescence (GE Healthcare, NJ, USA)
and autoradiography by using BioMax LightFilm (Eastman Kodak,
New Heaven, CT, USA) (Ho et al., 2013).
2.9. Statistical analysis
Results were expressed as mean ± SD in triplicate (n = 3). The dif-
ferences between PEITC-treated or TMZ-treated and control groups
were analyzed by using one way ANOVA or the Student’s t-test. The
p value of less than 0.05 was considered a signiﬁcant difference,
*p < 0.05; #p < 0.05.
3. Results
3.1. PEITC induced cell morphological changes and decreased the
viability of GBM8401 cells
To realize the cytotoxic effects of PEITC, GBM 8401 cells were
treated with 0, 4, 6, 8, 10, 12, and 14 μM PEITC for 24 h or treated
with 500 μM TMZ for 24 h. Marked morphological changes of GBM
8401 cells based on cells became smaller, round and blunt in size
and some ﬂoated on medium were induced by PEITC in a dose-
dependent manner (Fig. 1A). The total percentages of viable cells
(A)
(B)
Fig. 1. PEITC and TMZ induced cell morphological changes and decreased the percentage of viable GBM 8401 cells. Cells were treated with different concentrations (4–
14 μM) of PEITC for 24 h and cells morphological changes were examined under phase contrast microscope at 200× (A) and cells were harvested to measure the percentage
of viable cells by ﬂow cytometric assay (B). The values presented are the mean ± S. D. (n = 3) from three independent experiments. Different letters (a–f) represent signif-
icant differences among PEITC-treated at 24 h (p < 0.05). Different letters (a–g) represent signiﬁcant differences among PEITC-treated at 48 h (p < 0.05). TMZ: temozolomide.
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were measured by ﬂow cytometric assay, PEITC decreased the per-
centage of viable GBM 8401 cells in a dose- and time-dependent
manner, and TMZ also decreased the percentage of viable GBM 8401
cells (Fig. 1B). The total viable cells were signiﬁcantly decreased in
GBM 8401 cells exposed to at least 6 μM PEITC, and by more than
50% in cells exposed to 10 μM PEITC after 48 h-treatment. Thus the
concentration of 8 μM was selected in further experiments.
3.2. PEITC induced sub-G1 phase in GBM 8401 cells
The distribution of cell cycle was examined by ﬂow cytometry
after incubation with PEITC for 48 h to further examine the effects
of PEITC on the cell numbers of GBM 8401 (Fig. 2A and B). The ac-
cumulation of the DNA contents of the GBM 8401 cells exposed to
8 μM of PEITC was signiﬁcantly increased up to 25% in the G0/G1
phase in contrast to the control (Fig. 2A). The accumulation of sub-
G1 phase of the cells exposed to 4, 6, 8 μM of PEITC was signiﬁcantly
increased in contrast to the control (Fig. 2B). Then these cells were
analyzed after Annexin-V/PI staining by ﬂow cytometry to conﬁrm
the induction of sub-G1 phase of GBM 8401 cells exposed to PEITC
(Fig. 2C). Results indicated that PEITC signiﬁcantly induced apop-
tosis in GBM 8401 cells.
3.3. PEITC promoted ROS and Ca2+ release and attenuated the levels
of mitochondria membrane potential (ΔΨm) in GBM 8401 cells
Whether the induction of apoptosis in GBM 8401 cells by PEITC
through ROS and Ca2+ productions involved the levels of ΔΨmwere
investigated in further experiments. ROS productions were in-
creased after GBM 8401 cells were exposed to 8 μM of PEITC for 24,
48 h, but not after cells were exposed to 500 μM of PEITC (Fig. 3A).
The levels of ΔΨmwere decreased after GBM 8401 cells were treated
with PEITC and TMZ (Fig. 3B). Fluo-3/AM exhibits an increase in ﬂu-
orescence when it binds Ca2+ in the cells after being treated with
PEITC. So increases in ﬂuorescence indicate an increase in [Ca2+]I,
consistent with cells that are functionally compromised. PEITC in-
creased in [Ca2+]I in GBM 8401 cells, but TMZ decreased it (Fig. 3C).
These PEITC effects were in a time-dependent manner. These results
indicated that PEITC induced growth inhibition through the ROS pro-
duction, Ca2+ release, and with involvement of mitochondria in GBM
8401 cells.
3.4. PEITC induced caspase-8 and -9 activities in GBM 8401 cells
GBM 8401 cells were treated with or without PEITC, TMZ before
cells were harvested, and the activities of caspase-8, -9 and -3 and
percentage of viable cells were measured by ﬂow cytometric assay
to conﬁrmwhether caspases were involved in the apoptosis induced
by PEITC or TMZ. Caspase-3 activity was not signiﬁcantly affected
after cells were exposed to 8 μM PEITC for 24, 48 h (Fig. 4A). But
caspase-8 and -9 activities were signiﬁcantly increased after cells
were exposed to 8 μM PEITC for 24, 48 h (Fig. 4B and C). Caspase-
3, -8 and -9 activities were signiﬁcantly decreased after cells were
exposed to 500 μM TMZ for 24, 48 h (Fig 4A–C). Therefore caspase-8
and -9 were involved in apoptosis induced by PEITC in GBM 8401
cells.
3.5. PEITC affected apoptosis associated protein levels in GBM 8401
cells
PEITC induced apoptosis in GBM 8401 cells disclosed by the
results from ﬂow cytometric assay. To investigate protein associ-
ated with apoptosis, the protein levels were examined by Western
blotting assay after GBM8401 cells were treated with PEITC (6, 8 μM)
(Fig. 5). Anti-apoptotic proteins such as Bcl-2, Mcl-1 and Bcl-xl were




Fig. 2. PEITC induced sub-G1 phase and apoptosis in GBM 8401 cells. Cells were
treated with different concentrations (4–8 μM) of PEITC for 48 h, and were har-
vested to measure the cell cycle distribution as described in Materials and Methods.
(A) The percentage of cells in G0/G1, S and G2/M phase of cell cycle. (B) The per-
centage of cells in sub-G1 phase. (C) The percentage of cell in apoptosis after cells
were treated with 8 μM PEITC. The values presented are the mean ± S. D. (n = 3) from
three independent experiments. Signiﬁcantly different from vehicle control treated
cells at *p < 0.05 . C, Ctl: control.
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Bak were increased (Fig. 5B); the levels of caspase-3, -9, -8, -2, and
-4 (Fig. 5C), FADD, Fas, Fas-L and TRAIL (Fig. 5D), Apaf-1, Endo G, Cyto
c, AIF, PARP (Fig. 5E) were enhanced; but XIAP was inhibited (Fig. 5E)
in GBM 8401 cells. The protein expression of GADD153, GRP 78 and
XBP-1 (Fig. 5F), IRE-1α, Calpain 1 and 2 (Fig. 5G) that is associated
with ER stress was promoted in GBM 8401 treated with PEITC. PEITC
increased the levels of Mn SOD and Cu/Zn SOD but inhibited cata-
lase and GST that are associated with ROS production in GBM 8401
cells (Fig. 5H).
4. Discussion
The effects of PEITC on human glioma cells have been studied
(Gupta et al., 2013; Lee et al., 2014). Our study disclosed that PEITC
induced apoptosis of human brain glioblastoma cells inmany aspects.
PEITC induced cytotoxic effects on GBM 8401 human glioblas-
toma multiforme cells in vitro: it changed the morphology and
decreased the viability of GBM 8401 cells in a dose- and time-
dependent manner (Fig. 1A and B). The current chemotherapy agent
for glioblastomas, TMZ also decreased the percentage of viable GBM
8401 cells and showed its cytotoxic effects (Fig. 1B). How did PEITC
affect the cell cycle of GBM 8401 cells? PEITC signiﬁcantly in-
creased the accumulation of the DNA contents of the GBM 8401 cells
up to 25% in the G0/G1 phase in contrast to the control (Fig. 2A). It
also signiﬁcantly increased the accumulation of sub-G1 phase
(apoptotic population) of the cells in contrast to the control and in
a dose-dependent manner (Fig. 2B). Therefore PEITC signiﬁcantly
induced apoptosis in GBM 8401 cells.
PEITC induced growth inhibition through the ROS production,




Fig. 3. PEITC affected ROS and Ca2+ production and levels of mitochondria membrane potential (ΔΨm) in GBM 8401 cells. Cells were treated with (experimental group) or
without PEITC (8 μM) (control group), TMZ (500 μM) (positive control) for different time periods before being harvested to measure the ROS production by H2DCF-DA (A),
the levels of ΔΨm by DiOC6 (B), and Ca2+ production by Flou-3/AM (C) were analyzed by ﬂow cytometric assay as described in Materials and Methods. The values pre-
sented are the mean ± S. D. (n = 3) from three independent experiments. Signiﬁcantly different from vehicle control treated cells at *,#p < 0.05. C: control, TMZ: temozolomide.
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(Fig. 3). PEITC increased the levels of Mn SOD and Cu/Zn SOD, but
inhibited catalase and GST that are associated with ROS produc-
tion in GBM 8401 cells (Fig. 5H). On the contrary, TMZ did not
increase ROS production, Ca2+ release, but is with involvement of
mitochondria changes in GBM 8401 cells (Fig. 3). TMZ can induce
mitochondrial damage, such as the loss of ΔΨm, and lead to a de-
crease of mitochondrial mass in human glioblastoma U87 MG cells,
which suggests that mitochondrial damage might play the role in
TMZ-induced cell death (Lin et al., 2012).
Apoptotic pathways include the extrinsic (cytoplasmic, death
receptor) and intrinsic (mitochondrial) pathways (Ghobrial et al.,
2005; Jin and El-Deiry, 2005). The central effectors of apoptosis
are caspases. Cell surface death receptors, such as Fas, tumor ne-
crosis factor receptor, or TRAIL receptors are mediated through the
extrinsic pathway. The extrinsic death receptor signaling pathway
involving the Fas and FasL activates FADD followed by activation
of caspase-8, then either activates caspase-3 directly to cause
apoptosis or results in Bad activation to affect pro-apoptotic or anti-
apoptotic protein expression before leading to mitochondria-
mediated pathway (Budihardjo et al., 1999; Wolf and Green, 1999;
Zhai et al., 2014). The caspase-dependent pathway involves the
Fas receptor then promotes the activations of initiator caspases
(caspase-8 and -9), executioner caspases (caspase-3) for induc-
tion of apoptosis (Ghobrial et al., 2005; Jin and El-Deiry, 2005;
McIlwain et al., 2013). In our study, PEITC promoted FADD, Fas,
Fas-L and TRAIL (Fig. 5D); PEITC did not signiﬁcantly affect caspase-3
activity (Fig. 4A), but increased caspase-8 and -9 activities (Fig. 4B
and C); PEITC enhanced the levels of caspase-3, -9, -8, -2, and -4
(Fig. 5C). Consequently, activations of initiator caspases (caspase-8
and -9) and increased expressions of caspase-3, -9, -8, -2, and -4
might involve the PEITC-induced apoptosis of GBM 8401 cells. Nev-
ertheless, TMZ signiﬁcantly decreased caspase-3, -8 and -9 activities
(Fig. 4A–C). TMZ signiﬁcantly increased the activity of caspase 3
and caspase 9, but did not change the caspase 8 activity in human
glioblastoma multiforme T98G cells (European Collection of Cell
Cultures) (Jakubowicz-Gil et al., 2013). Thus, TMZ has various effects
on caspases or induces apoptosis through different pathways in
different glioblastoma cell lines, and personalized treatments for
glioblastoma are necessary.
The intrinsic (mitochondrial) pathways result in the release of
apoptosis-inducing factor (AIF) or endonuclease G (Endo G) to cause
apoptosis (Saelens et al., 2004; Wajant, 2002). Cytochrome c initi-
ates a caspase cascade by advancing apoptosome formation to
provide the expression of apoptotic protease-activating factor-1
(Apaf-1). Our data indicated that PEITC enhanced Endo G, Cyto c,
Apaf-1 in GBM 8401 cells (Fig. 5E). PEITC decreased anti-apoptotic
proteins such as Bcl-2, Mcl-1 and Bcl-xl (Fig. 5A; increased pro-
apoptotic proteins such as Bax, Bad, Bid and Bak (Fig. 5B); but
inhibited XIAP (Fig. 5E) that is associated with apoptosis progres-
sion in GBM 8401 cells. According to these observations above, we
suggest that PEITC induces apoptosis also through intrinsic (mito-
chondrial) pathways as well as extrinsic (death receptor) ones.
Endoplasmic reticulum (ER) stress has been considered one of
the factors to lead to diseases through ER stress-induced apopto-
sis (Cui et al., 2013; Hamamura and Yokota, 2007). In animal
knockoutmodels, GADD153mediates apoptosis induced by ER stress
in pancreatic cells and by ischemic stress induced in brain neuro-
nal cells (Oyadomari et al., 2002; Tajiri et al., 2004). GADD153 induces
the expression of the pro-apoptotic Bcl protein, Bak, and the trans-
location of Bax from the cytosol to the mitochondria (Gotoh et al.,
2004; Lovat et al., 2003). ER stress markers include GADD153, GRP
78, IRE-1α, XBP-1 (Gotoh et al., 2004; Kim et al., 2007; Lovat et al.,
2003; Oyadomari et al., 2002; Tajiri et al., 2004). In our study, PEITC
promoted the protein expression of GADD153, GRP 78 and XBP-1
(Fig. 5F), IRE-1α, Calpain 1 and 2 (Fig. 5G) that are associated with




Fig. 4. PEITC induced caspase-3, -8 and -9 activities in GBM 8401 cells. Cells were
treated with or without PEITC, TMZ before cells were harvested and activities of
caspase-3 (A), -8 (B) and -9 (C) were measured by ﬂow cyomteric assay as de-
scribed in Materials and Methods. The values presented are the mean ± S. D. (n = 3)
from three independent experiments. Signiﬁcantly different from vehicle control
treated cells at *,#p < 0.05. C: control, TMZ: temozolomide.







Fig. 5. PEITC affected apoptosis associated protein levels in GBM 8401 cells. Cells were treated with 6, 8 μM PEITC respectively for 0, 24 and 48 h and then were harvested
to measure the apoptotic associated proteins by Western blotting assay (A: Bcl-2, Mcl-1 and Bcl-x. B: Bax, Bad, Bid and Bak. C: Caspase-3, caspase-9, caspase-8, caspase-2
and caspase-4. D: FADD, Fas, Fas-L and TRAIL. E: Apaf-1, Endo G, cytochrome c, AIF, XIAP and PARP. F: GADD153, GRP 78 and XBP-1. G: IRE-1α, Calpain 1 and 2. H: Catalase,
GST, Mn SOD and Cu/Zn SOD) in GBM 8401 cells.
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5. Conclusions
Our experiments have established that PEITC has potent anti-
cancer activity through the induction of apoptosis in GBM 8401 cells,
and the possible signaling pathways are summarized (Fig. 6). PEITC
induces apoptosis through the extrinsic (death receptor) pathway
involving the Fas and FasL, then activating FADD followed by acti-
vation of caspase-8, then either activating caspase-3 directly or
through ROS production, dysfunction of mitochondria, AIF and Endo
G release from mitochondria before activating caspase-3 through
intrinsic (mitochondrial) pathway in GBM 8401 cells. Taken togeth-
er, these ﬁndings reveal the possible molecular mechanisms and
signaling pathways of the anti-cancer properties of PEITC for human
brain glioblastoma cells.
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